Award

Purchase Order #75F40126P00176

FDA Terminates Cyprotex Scientific Services Purchase Order

Buyer

Food and Drug Administration

Award Amount

$70,500.00

Ceiling

$70,500.00

Period of Performance

Sep 01, 2026 – Oct 09, 2026

Identifier

75F40126P00176

NAICS

541690

This purchase-order modification terminates, for the government’s convenience, an order with Cyprotex US LLC, a provider of laboratory testing and bioanalytical services used in pharmaceutical research. The original order was intended to provide specialized scientific support for government research, but the available record does not specify the tests, deliverables, or reason for termination. The modification ends the planned work; it does not establish that services were completed. Its effect is to change the agency’s planned research support, though broader implications are not stated. The record does not identify whether the order was competitively awarded or sole-source, or provide a contract vehicle, acquisition program, subcontractors, prior related contracts, or original solicitation details. Performance was planned as a brief engagement in Framingham, Massachusetts, and the order was recently modified to terminate.

Description

THE PURPOSE OF THIS MODIFICATION IS TO TERMINATE OF THE CONTRACT FOR CONVENIENCE OF THE GOVERNMENT.

View original record